Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.

Journal of clinical laboratory analysis - 1 May 2021

Xia Junbo, Luo Man, Dai Lujun, Wang Liusheng, Wang Limin, Zhu Jing

Abstract excerpt

BACKGROUND: Current therapeutic drugs show positive effects on non-small-cell lung cancer (NSCLC) patients with mutant epidermal growth factor receptor (EGFR) expression, whereas a lesser beneficial effect is generally noted on NSCLC patients with wild-type EGFR. Therefore, identification of new detection methods for the accurate clinical diagnosis of NSCLC is essential. METHODS: In this study, tumor-derived...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to ErbB Receptors

Share to Exosomes

Share to Gene Ontology

Share to MicroRNAs

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 33682961
DOI: 10.1002/jcla.23743
PMCID: PMC8128312

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.PMID 33682961Read ↗

Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation.Semantic proximity Read ↗

Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer.Semantic proximity Read ↗

Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.Semantic proximity Read ↗

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patientsSemantic proximity Read ↗

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patientsSemantic proximity Read ↗

Elevated Exosome-derived Mirnas Predict Osimertinib Resistance in Non-small Cell Lung CancerSemantic proximity Read ↗

Urinary exosomal long noncoding RNAs serve as biomarkers for early detection of non-small cell lung cancerSemantic proximity Read ↗

Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancerSemantic proximity Read ↗

Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancerSemantic proximity Read ↗

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancerSemantic proximity Read ↗

A plasma miRNA-based classifier for small cell lung cancer diagnosisSemantic proximity Read ↗

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.